Independent Research GmbH Analysts Give AstraZeneca plc (AZN) a GBX 3,650 Price Target


The firm presently has a a "sell" rating on the biopharmaceutical company's stock. Independent Research GmbH's target price suggests a potential downside of 6.37% from the company's previous close.



from Biotech News